BioCell Technology, headquartered in Germany, is a leading innovator in the biotechnology industry, specialising in the development of advanced nutritional supplements and health products. Founded in 1997, the company has established a strong presence in major operational regions across Europe and North America, focusing on enhancing human health through scientifically-backed formulations. The core offerings of BioCell Technology include its flagship product, BioCell Collagen®, a patented ingredient renowned for its unique composition of hydrolysed collagen, chondroitin sulphate, and hyaluronic acid. This product stands out for its ability to support joint health, skin hydration, and overall wellness. With a commitment to quality and efficacy, BioCell Technology has garnered a notable market position, recognised for its contributions to the health and wellness sector.
How does BioCell Technology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BioCell Technology's score of 15 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BioCell Technology, headquartered in Germany (DE), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that BioCell Technology may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within an increasingly eco-conscious market, it may benefit from developing and communicating clear climate commitments to align with global sustainability trends.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BioCell Technology has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
